Cargando…
SP6616 as a Kv2.1 inhibitor efficiently ameliorates peripheral neuropathy in diabetic mice
BACKGROUND: Diabetic peripheral neuropathy (DPN) is a common complication of diabetes severely afflicting the patients, while there is yet no effective medication against this disease. As Kv2.1 channel functions potently in regulating neurological disorders, the present work was to investigate the r...
Autores principales: | Zhu, Xialin, Chen, Yun, Xu, Xu, Xu, Xiaoju, Lu, Yin, Huang, Xi, Zhou, Jinpei, Hu, Lihong, Wang, Jiaying, Shen, Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581884/ https://www.ncbi.nlm.nih.gov/pubmed/33096484 http://dx.doi.org/10.1016/j.ebiom.2020.103061 |
Ejemplares similares
-
Antispasmodic Drug Drofenine as an Inhibitor of Kv2.1 Channel Ameliorates Peripheral Neuropathy in Diabetic Mice
por: Xu, Xiaoju, et al.
Publicado: (2020) -
SP6616 as a new Kv2.1 channel inhibitor efficiently promotes β-cell survival involving both PKC/Erk1/2 and CaM/PI3K/Akt signaling pathways
por: Zhou, T T, et al.
Publicado: (2016) -
Pentameric assembly of the Kv2.1 tetramerization domain
por: Xu, Zhen, et al.
Publicado: (2022) -
Peroxisomal dysfunctions cause lysosomal storage and axonal Kv1 channel redistribution in peripheral neuropathy
por: Kleinecke, Sandra, et al.
Publicado: (2017) -
Auxiliary KCNE subunits modulate both homotetrameric Kv2.1 and heterotetrameric Kv2.1/Kv6.4 channels
por: David, Jens-Peter, et al.
Publicado: (2015)